Penserra Capital Management LLC Hutchmed (China) LTD Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$28.89 - $35.33 $35,823 - $43,809	-1,240 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.66 - $42.94 $356 - $429	10 Added 0.81%	1,240 $45,000
Q2 2021 Aug 12, 2021	BUY	$23.7 - $39.27 $1,303 - $2,159	55 Added 4.68%	1,230 $48,000
Q1 2021 May 13, 2021	SELL	$27.01 - $36.8 $135 - $184	-5 Reduced 0.42%	1,175 $33,000
Q4 2020 Feb 12, 2021	BUY	$27.51 - $34.36 $20,962 - $26,182	762 Added 182.3%	1,180 $37,000
Q3 2020 Nov 13, 2020	BUY	$25.8 - $34.61 $10,784 - $14,466	418 New	418 $13,000

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.5B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.